Skip to main content
Clinical Trials/NCT06891053
NCT06891053Enrolling By InvitationNot Applicable

Studio TIARA: Alessitimia ed Emicrania Cronica

Azienda Sanitaria Locale di Alessandria1 site in 1 country350 target enrollmentStarted: May 30, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
350
Locations
1
Primary Endpoint
Degree of alexithymia

Study Overview

Brief Summary

The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity of the clinical phenotype of migraine, favoring its chronicization), in an analysis adjusted for psychiatric comorbidity (for anxiety and depression, potentially influencing migraine chronicization) and for personalogical factor represented by apathy.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
12 Years to 65 Years (Child, Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of episodic migraine with or without aura, chronic migraine and/or MOH according to ICHD-3 2018 criteria;
  • Patients aged 12-65 years;
  • Female patients

Exclusion Criteria

  • Ongoing major depressive episode;
  • Comorbidities for major internal diseases (hepatopathy, nephropathy, heart failure, etc.);
  • Alcohol or substance abuse disorder (eoin, cocaine, cannabis, hallucinogens);
  • Language barrier;
  • Low cultural/cognitive level;
  • No informed consent.

Outcomes

Primary Outcomes

Degree of alexithymia

Time Frame: In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval

Independent variable measured as a score on the TAS-20 scale

Migraine frequency

Time Frame: In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval

Secondary Outcomes

  • Number of "drug days" in patients diagnosed with MOH(In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval)
  • Degree of alessithymia in patients diagnosed with MOH(In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval)

Investigators

Sponsor
Azienda Sanitaria Locale di Alessandria
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Studio TIARA: Alessitimia ed Emicrania... | Clinical Trial